RPP

Acute respiratory infection remains the leading cause of death among young, geriatric, and immuno-comprised patients. As an infectious disease that interferes with normal breathing, the urgency to provide these patients access to modern technology is essential to detect multiple pathogens simultaneously. 

Unfortunately, many doctors must rely on rapid antigen detection tests for diagnosis and treatment. Although these tests do offer some value, they cause delayed diagnosis and poor clinical outcomes. They may also create a false sense of security for both the patient and doctor since false negatives can lead to a delayed diagnosis and poor clinical outcomes. This is due to their low sensitivity and focus on pathogen diagnosis.

MHS Labs offers a fast and accurate solution using the most advanced technology for identifying pathogens and assisting with an accurate diagnosis.